PYC THERAPEUTICS ORDINARY (PYC) Short Interest
PYC THERAPEUTICS ORDINARY (ASX:PYC) had 0.36% of shares reported as short positions as of 26 June 2026, representing 3,588,548 shares. PYC THERAPEUTICS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
PYC
Pyc Therapeutics
PYC Therapeutics is a clinical-stage biotech company focused on developing RNA therapies to address genetic diseases. Their proprietary RNA delivery platform aims to provide safer and more effective treatments by targeting the underlying causes of these diseases. The company is advancing a pipeline of novel therapies for eye, central nervous system, and kidney diseases.